Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. Consider and adopt the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31, 2025; 2. Consider the Independent Reports'' of the Statutory Auditor on Standalone and Consolidated Financial Statements for the quarter and year ended March 31, 2025; 3. Other Business items. Further, in continuation to earlier disclosure dated March 26, 2025, regarding the closure of trading window w.e.f. April 01, 2025 in pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Audited Financial Results for the quarter and year ended March 31, 2025 for all designated persons, their immediate relatives and all connected persons covered under the aforesaid code. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.